Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

CinCor Pharma, Inc. - Common Stock (NQ:CINC)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 23, 2023 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	29.16 (3)
Ask (Size)	29.25 (9)
Prev. Close	29.06
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	43,764,323
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat

February 21, 2023

From CinCor Pharma Inc

Via GlobeNewswire

There's a Lot to Love About Mineralys' Valentine's Day IPO

February 13, 2023

MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 million

Via MarketBeat

Performance

More News

These 2 Healthcare Stocks Have Doubled in 2023

February 01, 2023

Via MarketBeat

CINCOR PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC

January 24, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Where CinCor Pharma Stands With Analysts ↗

January 12, 2023

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT)

January 20, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Why These Two Biotech Stocks Blasted Higher This Week ↗

January 13, 2023

Via The Motley Fool

Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review ↗

January 13, 2023

Via Investor's Business Daily

CINCOR PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC

January 10, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

AstraZeneca Stock Nabs Breakout After $1.8 Billion CinCor Buyout ↗

January 10, 2023

Via Investor's Business Daily

January 10, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher ↗

January 09, 2023

Via Benzinga

Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 09, 2023

Via Benzinga

Stocks Building Off Of Friday's Rally ↗

January 09, 2023

Via Talk Markets

Nasdaq Surges Over 200 Points; Crude Oil Rises 2% ↗

January 09, 2023

Via Benzinga

CinCor Pharma (NASDAQ: CINC) Enters Into Agreement to be Acquired by AstraZeneca (NASDAQ: AZN) for $1.3 Billion

January 09, 2023

Via Spotlight Growth

AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal ↗

January 09, 2023

Via Investor's Business Daily

Why Is CinCor (CINC) Stock Up 138% Today? ↗

January 09, 2023

Via InvestorPlace

Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday ↗

January 09, 2023

Via Benzinga

US Stocks Open Higher; Dow Rises 150 Points ↗

January 09, 2023

Via Benzinga

CINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CinCor Pharma, Inc. Is Fair to Shareholders

January 09, 2023

From Halper Sadeh LLC

Via Business Wire

Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories ↗

January 09, 2023

Via Benzinga

AstraZeneca To Acquire CinCor Pharma To Strengthen Cardiorenal Pipeline ↗

January 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 09, 2023

Via Benzinga

Frequently Asked Questions

Is CinCor Pharma, Inc. - Common Stock publicly traded?

Yes, CinCor Pharma, Inc. - Common Stock is publicly traded.

What exchange does CinCor Pharma, Inc. - Common Stock trade on?

CinCor Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for CinCor Pharma, Inc. - Common Stock?

The ticker symbol for CinCor Pharma, Inc. - Common Stock is CINC on the Nasdaq Stock Market

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.